DE3031990C2 - Gewinnung von Myeloperoxidase und Arzneipräparate mit einem Gehalt an diesem Enzym als Hauptbestandteil - Google Patents

Gewinnung von Myeloperoxidase und Arzneipräparate mit einem Gehalt an diesem Enzym als Hauptbestandteil

Info

Publication number
DE3031990C2
DE3031990C2 DE3031990A DE3031990A DE3031990C2 DE 3031990 C2 DE3031990 C2 DE 3031990C2 DE 3031990 A DE3031990 A DE 3031990A DE 3031990 A DE3031990 A DE 3031990A DE 3031990 C2 DE3031990 C2 DE 3031990C2
Authority
DE
Germany
Prior art keywords
myeloperoxidase
leukocytes
millimolar
obtaining
manganese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3031990A
Other languages
German (de)
English (en)
Other versions
DE3031990A1 (de
Inventor
Eichi Hasegawa
Takashi Hirakata Kobayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP17210979A external-priority patent/JPS5696694A/ja
Priority claimed from JP2211380A external-priority patent/JPS56118018A/ja
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Publication of DE3031990A1 publication Critical patent/DE3031990A1/de
Application granted granted Critical
Publication of DE3031990C2 publication Critical patent/DE3031990C2/de
Expired legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B5/00—Packaging individual articles in containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, jars
    • B65B5/02—Machines characterised by incorporation of means for making the containers or receptacles
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y10S435/816—Enzyme separation or purification by solubility

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE3031990A 1979-12-28 1980-08-25 Gewinnung von Myeloperoxidase und Arzneipräparate mit einem Gehalt an diesem Enzym als Hauptbestandteil Expired DE3031990C2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17210979A JPS5696694A (en) 1979-12-28 1979-12-28 Separation of myeloperoxidase from human nyelogenic leukocite
JP2211380A JPS56118018A (en) 1980-02-22 1980-02-22 Drug composition containing myeloperoxidase as main constituent

Publications (2)

Publication Number Publication Date
DE3031990A1 DE3031990A1 (de) 1981-07-02
DE3031990C2 true DE3031990C2 (de) 1982-07-01

Family

ID=26359291

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3031990A Expired DE3031990C2 (de) 1979-12-28 1980-08-25 Gewinnung von Myeloperoxidase und Arzneipräparate mit einem Gehalt an diesem Enzym als Hauptbestandteil

Country Status (6)

Country Link
US (2) US4306025A (enExample)
AT (1) AT370997B (enExample)
DE (1) DE3031990C2 (enExample)
FR (1) FR2472609A1 (enExample)
IN (1) IN153488B (enExample)
SE (1) SE448882B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937192A (en) * 1983-05-24 1990-06-26 Cetus Corporation Fungal chloroperoxidase method
US4707447A (en) * 1983-05-24 1987-11-17 Cetus Corporation Fungal chloroperoxidase method
US4576817A (en) * 1984-06-07 1986-03-18 Laclede Professional Products, Inc. Enzymatic bandages and pads
SE8500341L (sv) * 1985-01-24 1986-07-25 Pharmacia Ab Desinfektionssats samt sett for desinfektion
US5460961A (en) * 1988-06-14 1995-10-24 La Region Wallonne Human myeloperoxidase and its therapeutic application
US5846799A (en) * 1988-06-14 1998-12-08 La Region Wallone Human myeloperoxidase and its therapeutic application
CA2114163C (en) * 1993-01-29 2002-04-30 Nobuo Nishiki Method for stabilizing antigenicity of myeloperoxidase
US7015022B2 (en) * 2002-06-07 2006-03-21 University Of Medicine & Dentistry Of New Jersey Mammalian catalase-dependent oxidation processes and methods for stimulating oxidative activities

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947324A (en) * 1975-04-21 1976-03-30 G. D. Searle And Co. Method for isolating high purity peroxidase
NL7610608A (nl) * 1976-09-24 1978-03-29 Akzo Nv Werkwijze voor het stabiliseren van peroxidase- -bevattende composities.

Also Published As

Publication number Publication date
FR2472609A1 (fr) 1981-07-03
US4379141A (en) 1983-04-05
IN153488B (enExample) 1984-07-21
SE448882B (sv) 1987-03-23
FR2472609B1 (enExample) 1983-10-21
DE3031990A1 (de) 1981-07-02
SE8005679L (sv) 1981-06-29
AT370997B (de) 1983-05-25
ATA436780A (de) 1982-10-15
US4306025A (en) 1981-12-15

Similar Documents

Publication Publication Date Title
EP0447585B1 (de) Verfahren zur Herstellung eines intravenös verträglichen Immunglobulin-G-Präparates
DE68922358T2 (de) Chromatographische Trennung von Plasmaproteinen, insbesondere von Faktor VIII, von Willebrand Faktor, von Fibronectin und von Fibrinogen.
EP0352500B1 (de) Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen immunoglobulin-Präparates mit hohemIgM-Gehalt.
DE68903558T2 (de) Verfahren zur inaktivierung von viren.
DE3686470T2 (de) Verfahren zur herstellung des alpha-1-proteinase-inhibitors.
DE68913383T2 (de) Rinderfaktor-Xa-hemmender Faktor und diesen enthaltende pharmazeutische Zusammensetzungen.
DE3402647C2 (de) Verfahren zur Gewinnung von koloniestimulierendem Faktor und Kallikrein aus menschlichem Urin
DE69124235T3 (de) Reinigung und verwendung von pertactin, eines bordetella pertussis aussenmembranproteins
DE2440529C3 (de) Hyaluronidase-Präparat aus menschlicher Plazenta
DE3031990C2 (de) Gewinnung von Myeloperoxidase und Arzneipräparate mit einem Gehalt an diesem Enzym als Hauptbestandteil
DE69425033T2 (de) Verfahren zur Sterilisierung einer menschliches, rekombinantes Serum-albumin enthaltenden pharmazeutischen Zusammensetzung
AT391808B (de) Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
EP0307002B1 (de) Verfahren zur Herstellung eines Antithrombin III-Konzentrates
EP0567448A1 (de) Verfahren zur Herstellung von Faktor VIII
DE69511392T2 (de) Verfahren zur trennung von protektiven verbindungen aus bordetella pertussis
DE3888571T2 (de) Stabilisierung von biologischen und pharmazeutischen Produkten während der Inaktivierung von viralen und bakteriellen Keimen.
DE1617805A1 (de) Verfahren zur Herstellung von Lysozym
AT402789B (de) Pharmazeutische präparation auf basis von plasmaproteinen
DE3001187C2 (enExample)
DE68918562T2 (de) Menschliche myeloperoxidase und therapeutische verwendung.
EP0120835A2 (de) Verfahren zur Inaktivierung von Unverträglichkeitsreaktionen verursachenden Substanzen
DE69011465T2 (de) Verwendung von Human-ADF (=Adult T-cell leukemia-derived factor) zur Herstellung von Medikamenten.
DE19600939C1 (de) Verfahren zur Trennung von IgG und IgA
DE2910745C2 (enExample)
DE2152112A1 (de) Antitumor- und Vaccinzubereitungen

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
D2 Grant after examination
8328 Change in the person/name/address of the agent

Free format text: VOSSIUS, V., DIPL.-CHEM. DR.RER.NAT. TAUCHNER, P., DIPL.-CHEM. DR.RER.NAT. HEUNEMANN, D., DIPL.-PHYS. DR.RER.NAT. RAUH, P., DIPL.-CHEM. DR.RER.NAT., PAT.-ANWAELTE, 8000 MUENCHEN

8339 Ceased/non-payment of the annual fee